157 related articles for article (PubMed ID: 25747697)
1. Culture and characterisation of canine mitral valve interstitial and endothelial cells.
Liu MM; Flanagan TC; Lu CC; French AT; Argyle DJ; Corcoran BM
Vet J; 2015 Apr; 204(1):32-9. PubMed ID: 25747697
[TBL] [Abstract][Full Text] [Related]
2. Reciprocal interactions between mitral valve endothelial and interstitial cells reduce endothelial-to-mesenchymal transition and myofibroblastic activation.
Shapero K; Wylie-Sears J; Levine RA; Mayer JE; Bischoff J
J Mol Cell Cardiol; 2015 Mar; 80():175-85. PubMed ID: 25633835
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of canine 2D cell cultures as models of myxomatous mitral valve degeneration.
Tan K; Markby G; Muirhead R; Blake R; Bergeron L; Fici G; Summers K; Macrae V; Corcoran B
PLoS One; 2019; 14(8):e0221126. PubMed ID: 31415646
[TBL] [Abstract][Full Text] [Related]
4. Development and Evaluation of a Tissue-Engineered Fibrin-based Canine Mitral Valve Three-dimensional Cell Culture System.
Liu MM; Flanagan TC; Jockenhovel S; Black A; Lu CC; French AT; Argyle DJ; Corcoran BM
J Comp Pathol; 2018 Apr; 160():23-33. PubMed ID: 29729718
[TBL] [Abstract][Full Text] [Related]
5. Comparison of cellular changes in Cavalier King Charles spaniel and mixed breed dogs with myxomatous mitral valve disease.
Lu CC; Liu MM; Culshaw G; French A; Corcoran B
J Vet Cardiol; 2016 Jun; 18(2):100-9. PubMed ID: 26860643
[TBL] [Abstract][Full Text] [Related]
6. Interstitial cells from dogs with naturally occurring myxomatous mitral valve disease undergo phenotype transformation.
Disatian S; Ehrhart EJ; Zimmerman S; Orton EC
J Heart Valve Dis; 2008 Jul; 17(4):402-11; discussion 412. PubMed ID: 18751470
[TBL] [Abstract][Full Text] [Related]
7. Morphological changes to endothelial and interstitial cells and to the extra-cellular matrix in canine myxomatous mitral valve disease (endocardiosis).
Han RI; Clark CH; Black A; French A; Culshaw GJ; Kempson SA; Corcoran BM
Vet J; 2013 Aug; 197(2):388-94. PubMed ID: 23465752
[TBL] [Abstract][Full Text] [Related]
8. Valvular interstitial cells suppress calcification of valvular endothelial cells.
Hjortnaes J; Shapero K; Goettsch C; Hutcheson JD; Keegan J; Kluin J; Mayer JE; Bischoff J; Aikawa E
Atherosclerosis; 2015 Sep; 242(1):251-260. PubMed ID: 26232165
[TBL] [Abstract][Full Text] [Related]
9. Reference models for mitral valve tissue engineering based on valve cell phenotype and extracellular matrix analysis.
Flanagan TC; Black A; O'Brien M; Smith TJ; Pandit AS
Cells Tissues Organs; 2006; 183(1):12-23. PubMed ID: 16974091
[TBL] [Abstract][Full Text] [Related]
10. Human and porcine aortic valve endothelial and interstitial cell isolation and characterization.
Nehl D; Goody PR; Maus K; Pfeifer A; Aikawa E; Bakthiary F; Zimmer S; Nickenig G; Jansen F; Hosen MR
Front Cardiovasc Med; 2023; 10():1151028. PubMed ID: 37408661
[TBL] [Abstract][Full Text] [Related]
11. A technique for in vitro culture of canine valvular interstitial cells.
Heaney AM; Bulmer BJ; Ross CR; Schermerhorn T
J Vet Cardiol; 2009 Jun; 11(1):1-7. PubMed ID: 19451044
[TBL] [Abstract][Full Text] [Related]
12. Activation of the Interleukin-33/ST2 Pathway Exerts Deleterious Effects in Myxomatous Mitral Valve Disease.
Garcia-Pena A; Ibarrola J; Navarro A; Sadaba A; Tiraplegui C; Garaikoetxea M; Arrieta V; Matilla L; Fernández-Celis A; Sadaba R; Alvarez V; Gainza A; Jover E; López-Andrés N
Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33669101
[TBL] [Abstract][Full Text] [Related]
13. Distribution of myofibroblasts, smooth muscle-like cells, macrophages, and mast cells in mitral valve leaflets of dogs with myxomatous mitral valve disease.
Han RI; Black A; Culshaw GJ; French AT; Else RW; Corcoran BM
Am J Vet Res; 2008 Jun; 69(6):763-9. PubMed ID: 18518656
[TBL] [Abstract][Full Text] [Related]
14. Valve Interstitial Cells Act in a Pericyte Manner Promoting Angiogensis and Invasion by Valve Endothelial Cells.
Arevalos CA; Berg JM; Nguyen JM; Godfrey EL; Iriondo C; Grande-Allen KJ
Ann Biomed Eng; 2016 Sep; 44(9):2707-23. PubMed ID: 26905695
[TBL] [Abstract][Full Text] [Related]
15. Characterization of cell motility in single heart valve interstitial cells in vitro.
Liu AC; Gotlieb AI
Histol Histopathol; 2007 Aug; 22(8):873-82. PubMed ID: 17503344
[TBL] [Abstract][Full Text] [Related]
16. Tryptophan hydroxylase 1 expression is increased in phenotype-altered canine and human degenerative myxomatous mitral valves.
Disatian S; Lacerda C; Orton EC
J Heart Valve Dis; 2010 Jan; 19(1):71-8. PubMed ID: 20329492
[TBL] [Abstract][Full Text] [Related]
17. A collagen-glycosaminoglycan co-culture model for heart valve tissue engineering applications.
Flanagan TC; Wilkins B; Black A; Jockenhoevel S; Smith TJ; Pandit AS
Biomaterials; 2006 Apr; 27(10):2233-46. PubMed ID: 16313955
[TBL] [Abstract][Full Text] [Related]
18. Apoptosis and abundance of Bcl-2 family and transforming growth factor β1 signaling proteins in canine myxomatous mitral valves.
Surachetpong S; Jiranantasak T; Rungsipipat A; Orton EC
J Vet Cardiol; 2013 Sep; 15(3):171-80. PubMed ID: 23816827
[TBL] [Abstract][Full Text] [Related]
19. Developmental pathways and endothelial to mesenchymal transition in canine myxomatous mitral valve disease.
Lu CC; Liu MM; Clinton M; Culshaw G; Argyle DJ; Corcoran BM
Vet J; 2015 Dec; 206(3):377-84. PubMed ID: 26586213
[TBL] [Abstract][Full Text] [Related]
20. Pathology, protein expression and signaling in myxomatous mitral valve degeneration: comparison of dogs and humans.
Aupperle H; Disatian S
J Vet Cardiol; 2012 Mar; 14(1):59-71. PubMed ID: 22364722
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
